Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Gordon Heidkamp

2PUBLICATIONS

28CO-AUTHORS

Gene and molecular therapyInnate immunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Oct 30, 2024

Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma.

Jan Eckmann, Tanja Fauti, Marlene Biehl

|Apr 09, 2017

DC subset-specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo.

Christian H K Lehmann, Anna Baranska, Gordon F Heidkamp

Pageof 1

Frequent Collaborators

1 joint publications

Christian H K Lehmann

1 joint publications

Lukas Heger

1 joint publications

Jennifer J Lühr

1 joint publications

Alana Hoffmann

1 joint publications

Katharina C Reimer

1 joint publications

Christin Brückner

1 joint publications

Michaela Seeling

1 joint publications

Didier Soulat

1 joint publications

Jeanette H W Leusen

1 joint publications

Diana Dudziak

Frequent Collaborators

1 joint publications

Christian H K Lehmann

1 joint publications

Lukas Heger

1 joint publications

Jennifer J Lühr

1 joint publications

Alana Hoffmann

Top Related Videos

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

See more related videos

Top Related Videos

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

See more related videos